Why the study?
Sudden cardiac death is the leading cause of death in Chagas disease, making risk stratification and prevention of timely concern given its increasing global presence.
Answers are grounded in this paper and cite their sources.
This review highlights the major predictors of sudden cardiac death in Chagas disease and emphasizes the lack of randomized controlled trials guiding the use of ICDs and anti-arrhythmic drugs in this population.
Chagas disease is an important public health problem in Latin America. However, migration and globalisation have resulted in the increased presence of Chagas disease worldwide. Sudden cardiac death is the leading cause of death in people with Chagas disease, most often due to ventricular fibrillation. Although more common in patients with documented ventricular arrhythmias, sudden cardiac death can also be the first manifestation of Chagas disease in patients with no previous symptoms or known heart failure. Major predictors of sudden cardiac death include cardiac arrest, sustained and non-sustained ventricular tachycardia, left ventricular dysfunction, syncope and bradycardia. The authors review the predictors and risk stratification score developed by Rassi et al. for death in Chagas heart disease. They also discuss the evidence for anti-arrhythmic drugs, catheter ablation, ICDs and pacemakers for the prevention of sudden cardiac death in these patients. Given the widespread global burden, understanding the risk stratification and prevention of sudden cardiac death in Chagas disease is of timely concern.
No takes yet. Share an insight, caveat, or question.
Keegan et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: